Pharmacogenetics
- 1 November 2000
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 39 (5), 315-325
- https://doi.org/10.2165/00003088-200039050-00001
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Cloning and Initial Characterization of the Human DPYD Gene PromoterBiochemical and Biophysical Research Communications, 2000
- Technologies for detecting genetic polymorphisms in pharmacogenomicsMolecular Diagnosis, 1999
- Inherited variations in drug-metabolizing enzymes: Significance in clinical oncologyMolecular Diagnosis, 1999
- Analysis of the dihydropyrimidine dehydrogenase polymorphism in a British populationBritish Journal of Clinical Pharmacology, 1996
- A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 1996
- Three Japanese patients with Crigler-Najjar syndrome type I carry an identical nonsense mutation in the gene for UDP-glucuronosyltransferaseJournal of Human Genetics, 1995
- Human Polymorphism in Drug Metabolism: Mutation in the Dihydropyrimidine Dehydrogenase Gene Results in Exon Skipping and Thymine UracilureaDNA and Cell Biology, 1995
- Dihydropyrimidine dehydrogenase activity in cancer patientsEuropean Journal Of Cancer, 1993
- Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemiaThe Journal of Pediatrics, 1991
- Familial Pyrimidinemia and Pyrimidinuria Associated with Severe Fluorouracil ToxicityNew England Journal of Medicine, 1985